Gut microbiota mediate vascular dysfunction in a murine model of sleep apnoea: effect of probiotics
European Respiratory Journal · 2023
DOI: 10.1183/13993003.00002-2022 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Respiratory Journal, 2023. Verfasst von Mohammad Badran und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Child Health and Child Health Research Institute, School of Medicine, University of Missouri, Columbia, MO, USA. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Sleep Apnea, Obstructive, Probiotics, Coronary Artery Disease. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIA NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Background
Obstructive sleep apnoea (OSA) is a chronic prevalent condition characterised by intermittent hypoxia (IH), and is associated with endothelial dysfunction and coronary artery disease (CAD). OSA can induce major changes in gut microbiome diversity and composition, which in turn may induce the emergence of OSA-associated morbidities. However, the causal effects of IH-induced gut microbiome changes on the vasculature remain unexplored. Our objective was to assess if vascular dysfunction induced by IH is mediated through gut microbiome changes.
Methods
Faecal microbiota transplantation (FMT) was conducted on C57BL/6J naïve mice for 6 weeks to receive either IH or room air (RA) faecal slurry with or without probiotics (VSL#3). In addition to 16S rRNA amplicon sequencing of their gut microbiome, FMT recipients underwent arterial blood pressure and coronary artery and aorta function testing, and their trimethylamine N -oxide (TMAO) and plasma acetate levels were determined. Finally, C57BL/6J mice were exposed to IH, IH treated with VSL#3 or RA for 6 weeks, and arterial blood pressure and coronary artery function assessed.
Results
Gut microbiome taxonomic profiles correctly segregated IH from RA in FMT mice and the normalising effect of probiotics emerged. Furthermore, IH-FMT mice exhibited increased arterial blood pressure and TMAO levels, and impairments in aortic and coronary artery function (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Child Health and Child Health Research Institute, School of Medicine, University of Missouri, Columbia, MO, USA.
- Department of Veterinary Pathobiology, University of Missouri, Columbia, MO, USA.
- University of Missouri Metagenomics Center, University of Missouri, Columbia, MO, USA.
- Department of Molecular Microbiology and Immunology, Molecular Pathogenesis and Therapeutics Program, University of Missouri, Columbia, MO, USA.
- Dalton Cardiovascular Research Center, University of Missouri, Columbia, MO, USA.
- Department of Biomedical Sciences, University of Missouri, Columbia, MO, USA.
ORCID-Profile: Mohammad Badran, Abdelnaby Khalyfa, Aaron C Ericsson, David Gozal
Förderung
- NHLBI NIH HHS
- NIA NIH HHS
- National Institutes of Health
Zitieren
APA
Badran, M., Khalyfa, A., Ericsson, A. C., Puech, C., McAdams, Z., Bender, S. B., & Gozal, D. (2023). Gut microbiota mediate vascular dysfunction in a murine model of sleep apnoea: effect of probiotics. European Respiratory Journal. https://doi.org/10.1183/13993003.00002-2022
Vancouver
Badran M, Khalyfa A, Ericsson AC, Puech C, McAdams Z, Bender SB, et al. Gut microbiota mediate vascular dysfunction in a murine model of sleep apnoea: effect of probiotics. European Respiratory Journal. 2023. doi:10.1183/13993003.00002-2022
BibTeX
@article{Badran2023,
author = {Badran, Mohammad and Khalyfa, Abdelnaby and Ericsson, Aaron C and Puech, Clementine and McAdams, Zachary and Bender, Shawn B and Gozal, David},
title = {Gut microbiota mediate vascular dysfunction in a murine model of sleep apnoea: effect of probiotics},
journal = {European Respiratory Journal},
year = {2023},
doi = {10.1183/13993003.00002-2022}
}
EUVIMED